News
DGAP-News: GRAMMER AG closes Financial Year 2021 with significantly higher revenue and earnings
![RM plc: Director/PDMR Performance Share Plan Awards:](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1pGS0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8466312ec58c81b6a241a0f980cbf402f6a0b652/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/kangaroo.png?locale=us)
RM plc: Director/PDMR Performance Share Plan Awards
DGAP-News: TAKKT AG: TAKKT to shape the future worlds of work and increase sales to EUR two billion by 2025
DGAP-News: PAION AG REPORTS ON FISCAL YEAR 2021
DGAP-News: ENCAVIS AG publishes first Sustainability Report in accordance with new GRI standard
DGAP-News: STRATEC SE: STRATEC GENERATES NEW RECORD SALES AND EARNINGS IN 2021 FINANCIAL YEAR
![indie Semiconductor Announces Retirement of Bill Woodward and Appointment of Diane Biagianti to Its Board of Directors](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
indie Semiconductor Announces Retirement of Bill Woodward and Appointment of Diane Biagianti to Its Board of Directors
indie Semiconductor (Nasdaq: INDI), an Autotech solutions innovator, today announced that Bill Woodward has retired and Diane Biagianti has been appointed to its board of directors. Biagianti
![McGrath RentCorp Sets First Quarter 2022 Financial Results Date and Time: https://mms.businesswire.com/media/20201210006044/en/1662/5/Corporate+jpeg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL203VlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3ead14cdcc69dacdfa743a453cf08e24d96f24fd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Corporate+.jpg?locale=us)
McGrath RentCorp Sets First Quarter 2022 Financial Results Date and Time
McGrath RentCorp (NASDAQ: MGRC) (the “Company”), a diversified business-to-business rental company, today announced plans to release financial results for its first quarter ending March 31, 2022
![AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results: https://mms.businesswire.com/media/20191108005662/en/711989/5/AGEX_High_Resolution_300dpi.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2s1RUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--00ef9f30c62ad613a4ffc2725532c06aa86f7fef/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AGEX_High_Resolution_300dpi.jpg?locale=us)
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth
![Alcoa Schedules First Quarter 2022 Earnings Release and Conference Call: https://mms.businesswire.com/media/20191121005110/en/566032/5/Alcoa_logo_horizontal_blue_%282%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXlrRWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--aaf6432637de856c3fef8280f7a36a58e26d954f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Alcoa_logo_horizontal_blue_-282-29.jpg?locale=us)
Alcoa Schedules First Quarter 2022 Earnings Release and Conference Call
Alcoa Corporation plans to announce its first quarter 2022 financial results on Wednesday, April 20, 2022 after the close of trading on the New York Stock Exchange.
The press release with
Fluor Joint Venture Receives Final Notice-to-Proceed on Interstate 35E Phase 2 Project in Dallas
Fluor Corporation (NYSE: FLR) announced today that Lone Star Constructors, its joint venture with Austin Bridge & Road, has been granted final notice-to-proceed by the Texas Department of
![UDR Announces Public Offering of 7,000,000 Shares of Common Stock: https://mms.businesswire.com/media/20191202005772/en/759858/5/UDR_-_Opening_Doors_to_the_Future_Logo_-_Trademarked.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlVIRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5bf07c004f8d98ead87d2e28ccc46b33cbfcc4a4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/UDR_-_Opening_Doors_to_the_Future_Logo_-_Trademarked.jpg?locale=us)
UDR Announces Public Offering of 7,000,000 Shares of Common Stock
UDR, Inc. (the “Company”) (NYSE: UDR), announced today that it is commencing an underwritten public offering of 7,000,000 shares of common stock in connection with the forward sale agreements
Walmart Announces 2022 Annual Shareholders’ Meeting Date
Walmart Inc. (NYSE: WMT) today announced that its Annual Shareholders’ Meeting will be held on Wednesday, June 1, 2022. The meeting will be held in a virtual-only format and will begin at 10:30
![ABIONYX Pharma Receives FDA Orphan Drug Designation (ODD) for CER-001 for the Treatment of LCAT Deficiency Presenting as Kidney Dysfunction and/or Ophthalmologic Disease: https://mms.businesswire.com/media/20210302005302/en/862456/5/ABIONYX_W.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM0FtVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3f52df4b7747dcabeb26ea260ead9545699cca5c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ABIONYX_W.jpg?locale=us)
ABIONYX Pharma Receives FDA Orphan Drug Designation (ODD) for CER-001 for the Treatment of LCAT Deficiency Presenting as Kidney Dysfunction and/or Ophthalmologic Disease
Regulatory News:
ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible) (Paris:ABNX), a new generation biotech company dedicated to the discovery and development of innovative therapies for
AIG Announces Proposed Senior Notes Offering by Corebridge Financial, Inc.
American International Group, Inc. (NYSE: AIG) today announced that its majority-owned subsidiary, Corebridge Financial, Inc., intends to offer senior unsecured notes (the “Notes”) in connection
![Keysight Selected by VTT to Support Open Testing and Integration Facility in Finland: https://mms.businesswire.com/media/20191105005173/en/754303/5/Keysight_Signature_Pref_Color.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1VqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bca68eb5e804e1802db2e2b6ef512db960c90ff6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Keysight_Signature_Pref_Color.jpg?locale=us)
Keysight Selected by VTT to Support Open Testing and Integration Facility in Finland
Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world
![DGAP-News: ENCAVIS AG shows significant growth in fiscal 2021 and forecasts an ongoing strong growth for 2022e](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
DGAP-News: ENCAVIS AG shows significant growth in fiscal 2021 and forecasts an ongoing strong growth for 2022e
![Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Olderhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use of their COVID-19 vaccine to include a second
![2022 Annual General Meeting: shareholders approve all proposals](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
2022 Annual General Meeting: shareholders approve all proposals
![Hancock Whitney Corporation to Announce First Quarter 2022 Financial Results and Host Conference Call April 19: https://mms.businesswire.com/media/20210106005743/en/1017051/5/HW_Logos_FINAL_Full_Color.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenphVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b5bdba0271e5fd97cb8ce67334183bc5b62e1268/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/HW_Logos_FINAL_Full_Color.jpg?locale=us)
Hancock Whitney Corporation to Announce First Quarter 2022 Financial Results and Host Conference Call April 19
Hancock Whitney Corporation (Nasdaq: HWC) will announce first quarter 2022 financial results on Tuesday, April 19, 2022 after the market closes. Management will host a conference call for analysts
![Humana Foundation $5.5 Million Investment Sustains Health Equity Momentum in Targeted Communities: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaXNCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--3d3c39355769d1759c5221ae0bf511106538ecb5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Humana_logo.png?locale=us)
Humana Foundation $5.5 Million Investment Sustains Health Equity Momentum in Targeted Communities
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, continued its $5.5 million investment in six communities across the United States to improve greater
![Itron and Emerson Collaborate to Offer Smart Thermostats for Demand Response Programs: https://mms.businesswire.com/media/20200123005801/en/769326/5/Itron_Bidgely_logo_FINAL.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMUk5SHc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--eb94aac188d0b9d56d4ba4f76d9605a63c9bef7c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Itron_Bidgely_logo_FINAL.jpg?locale=us)
Itron and Emerson Collaborate to Offer Smart Thermostats for Demand Response Programs
Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, is collaborating with Emerson, a global technology and engineering leader, to offer reliable
![Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNEFWS2c9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ff1977c5f19c19899ef789fb8e692387f41c81f2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/BusinessWireLogo.jpg?locale=us)
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has received a Phase II
![Guidewire Announces Latest Group of PartnerConnect Consulting Program Specialization Recipients: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBei8vT3c9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--59ca41c19ab90b527b0007dec2aaf96657dd0448/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg?locale=us)
Guidewire Announces Latest Group of PartnerConnect Consulting Program Specialization Recipients
Guidewire (NYSE: GWRE) announced that specializations have been awarded to two Guidewire PartnerConnect Consulting partners for the Americas (AMER) and Europe (EMEA).
The PartnerConnect Consultin